| Old Articles: <Older 1111-1120 Newer> |
 |
The Motley Fool February 27, 2004 Alyce Lomax |
A Time for Four Seasons? Hotels all agree that it's going to be a better year for lodging.  |
The Motley Fool February 27, 2004 Dave Marino-Nachison |
Out in the Kohl's The retailer's sales keep booming, but expenses are pressuring profits.  |
The Motley Fool February 27, 2004 W.D. Crotty |
Track This Small Cap LoJack may not be a can't-lose investment, but it's worth watching.  |
The Motley Fool February 27, 2004 Alyce Lomax |
Genentech's Hope For the past two days, Genentech has been an example of what many investors hinge their hopes and dollars on. Yesterday's FDA approval of the company's groundbreaking cancer drug, Avastin, was the reason positive sentiment remained infectious today.  |
The Motley Fool February 27, 2004 Bill Mann |
Payless: They're Not Kidding Lower sales, higher marketing expenditures, but a lower-than-expected loss. What's not to like?  |
The Motley Fool February 27, 2004 Seth Jayson |
Chinadotcom's Greedy Growth An acquisition-driven growth strategy makes for misleading growth numbers.  |
The Motley Fool February 27, 2004 Seth Jayson |
IHOP's Straight Talk Decreased earnings in a reorganization year don't tell the whole story at IHOP.  |
The Motley Fool February 27, 2004 Dave Marino-Nachison |
Rocky's on a Roll The hot shoe company's 2003 was a good one for Rocky and its investors.  |
The Motley Fool February 27, 2004 Rich Smith |
Ceradyne-o-mite! The ceramics maker posted stellar earnings growth of 350% for the fourth quarter.  |
The Motley Fool February 27, 2004 Rick Aristotle Munarriz |
Five More Stocks Under $10 5 companies whose stocks trade at under $10. Intelligroup... Six Flags... GSI Commerce...etc.  |
| <Older 1111-1120 Newer> Return to current articles. |